COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
Osteoarthritis (OA) is among challenging problems of clinical medicine, not only due to its high prevalence, but also because of higher burden of comorbidities. Previously we described a clinical phenotype of OA associated with type 2 diabetes mellitus (OADM), which is one of OA phenotypes character...
Main Authors: | I. V. Shirinsky, O. V. Sazonova, N. Yu. Kalinovskaya, V. S. Shirinsky |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2015-10-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/924 |
Similar Items
-
CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: I. V. Shirinsky, et al.
Published: (2016-01-01) -
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2015-03-01) -
DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
by: E. V. Kazygasheva, et al.
Published: (2016-08-01) -
Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study
by: V. S. Shirinsky, et al.
Published: (2020-12-01) -
THE PRODUCTION OF PRO- AND ANTIINFLAMMATORY CYTOKINES BY SYNOVIAL FIBROBLASTS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN VITRO WHEN USING DNA METHYLATION MODULATORS - INVESTIGATIVE STUDY
by: M. A. Shnayder, et al.
Published: (2019-05-01)